# A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients

> **NCT06665815** · — · RECRUITING · sponsor: **Rabin Medical Center** · enrollment: 20000 (estimated)

## Conditions studied

- Type 1 Diabetes
- Autoantibodies Screening

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06665815
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-15
- **Primary completion:** 2027-12-15
- **Final completion:** 2028-02-15
- **Target enrollment:** 20000 (ESTIMATED)
- **Last updated:** 2025-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665815, "A National Screening Program for Islet Autoantibodies Among First-degree Relatives of T1D Patients". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06665815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
